Rationale and design of a randomised double-blind 2×2 factorial trial comparing the effect of a 3-month intensive statin and antiplatelet therapy for patients with acute mild ischaemic stroke or high-risk TIA with intracranial or extracranial atherosclerosis (INSPIRES)

BACKGROUND: It remains unclear if intensive antiplatelet and statin treatments begun within 24–72 hours of cerebral ischaemic events from intracranial or extracranial atherosclerosis is effective or safe. METHODS: The Intensive Statin and Antiplatelet Therapy for High-risk Intracranial or Extracrani...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Ying, Pan, Yuesong, Han, Shangrong, Chen, Weiqi, Jing, Jing, Wang, Chunjuan, Yang, Yingying, Wang, Tingting, Meng, Xia, Zhao, Xingquan, Liu, Liping, Li, Hao, Johnston, S Claiborne, Amarenco, Pierre, Bath, Philip M, Wang, Yongjun, Wang, Yilong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359782/
https://www.ncbi.nlm.nih.gov/pubmed/36707080
http://dx.doi.org/10.1136/svn-2022-002084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359782/
https://www.ncbi.nlm.nih.gov/pubmed/36707080
http://dx.doi.org/10.1136/svn-2022-002084

Ejemplares similares